These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 4150556)

  • 1. Proceedings: A solid dosage form with constant release.
    Lerk CF; Bolink WJ; Zuurman K
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:151P. PubMed ID: 4150556
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tablets. XVII. Effect of pressure on the liberation in vitro of sodium salicylate from prolonged-action tablets].
    Terrier JL; Cruaud-Mangenot O; Duchène D; Puisieux F
    Pharm Acta Helv; 1976; 51(5):144-52. PubMed ID: 967910
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: The effects of granule porosity and strength on the porosity, air permeability and tensile strength of tablets.
    Healey JN; Humphreys-Jones JF; Walters V
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:110P. PubMed ID: 4150504
    [No Abstract]   [Full Text] [Related]  

  • 4. The physical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations.
    Sznitowska M; Płaczek M; Klunder M
    Acta Pol Pharm; 2005; 62(1):25-9. PubMed ID: 16022490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of a sustained release potassium chloride tablet.
    Lötter AP; van Wyk JJ; van Oudtshoorn MC
    Pharm Weekbl; 1972 Jan; 107(4):47-50. PubMed ID: 5061205
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: The effect of surface coatings on the dissolution rate of a non-disintegrating solid (potassium chloride).
    Fee JV; Grant DJ; Newton JM
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:149P-150. PubMed ID: 4150554
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained release tablets for potassium chloride administration. A pharmacological study.
    Bervenmark H; Eriksson G; Ljungberg S; Paalzow L
    Acta Pharm Suec; 1966 Feb; 3(1):45-58. PubMed ID: 5909431
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypokalemia, potassium loss and liver cirrhosis. Value of potassium chloride sustained-release tablets].
    Lévy VG; Caroli J
    Therapeutique; 1971 Dec; 47(10):845-51. PubMed ID: 5145546
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release from methyl acrylate-methyl methacrylate copolymer matrix. I. Kinetics of release.
    Farhadieh B; Borodkin S; Buddenhagen JD
    J Pharm Sci; 1971 Feb; 60(2):209-12. PubMed ID: 4396713
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: The effect of solvent flow on the dissolution rate of a non-disintegrating solid (potassium chloride).
    Fee JV; Grant DJ; Newton JM
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:148P-149. PubMed ID: 4150553
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on tablets. XV. Holocellulose and technical cellulose as substances promoting the disintegration of tablets].
    Malý J; Chalabala M; Heliová M; Necesaný V
    Cesk Farm; 1967 May; 16(4):194-7. PubMed ID: 6080493
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of sintering on the pore structure and strength of plastic matrix tablets.
    Rowe RC; Elworthy PH; Ganderton D
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:12P-16P. PubMed ID: 4150528
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of lubricants in the development of tablet formula.
    Surén G
    Dan Tidsskr Farm; 1971; 45(10):331-8. PubMed ID: 5143689
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
    Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of mucoadhesive dosage form containing rosiglitazone maleate.
    Krishna SS; Ray S; Thakur RS
    Pak J Pharm Sci; 2006 Jul; 19(3):208-13. PubMed ID: 16935828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.